|
| Lifecycle Phase |
What (Data / Elements / Products) |
How (Processes / Functions) |
Where (Locations / Networks) |
Who (Stakeholders / Actors) |
When (Timeframes / Events) |
Why (Goals / Motivations) |
|
|
| 1. Conception & Initiation |
Epidemiological data, mortality statistics, cost-of-smoking studies, FCTC provisions, draft mission statement |
Situational analysis, stakeholder mapping, advocacy planning |
Federal policy circles (Congress, HHS), state health departments, public health summits |
CDC Office on Smoking and Health, FDA CTP, Surgeon General, advocacy NGOs, tribal health leaders |
Initial policy momentum periods, post-Surgeon General reports, pre-election cycles |
Build mandate for tobacco control, align with WHO FCTC, secure funding and political commitment |
|
| 2. Policy & System Design |
Draft legislation, regulatory frameworks, taxation policy drafts, organizational charts, performance metric templates |
Legislative drafting, regulatory impact analysis, organizational design, budget allocation |
Capitol Hill, state legislatures, federal agencies, state DOHs |
Federal lawmakers, state legislators, public health lawyers, economic analysts, advocacy coalitions |
Legislative sessions, budget cycles, FCTC reporting deadlines |
Create enforceable, evidence-based laws and structures for tobacco control |
|
| 3. Implementation & Operation |
Public campaign materials, Quitline infrastructure, NRT stock, inspection reports, compliance databases |
Campaign deployment, cessation service delivery, retailer inspections, tax collection enforcement |
Community health centers, schools, retail outlets, enforcement field offices |
Public health educators, Quitline staff, enforcement officers, local NGOs |
Annual public health campaign launches, quarterly compliance sweeps, continuous cessation service availability |
Reduce smoking initiation, support quitting, ensure compliance with laws |
|
| 4. Evaluation & Adaptation |
Surveillance datasets, program evaluation reports, illicit trade detection data, vaping prevalence surveys |
Data analysis, policy review, stakeholder feedback collection, regulatory adjustment |
National data repositories, research institutions, policy workshops |
Epidemiologists, academic researchers, policymakers, advocacy leaders |
Annual CDC surveys (e.g., NHIS, YRBSS), biennial program evaluations |
Improve program effectiveness, respond to emerging products and threats |
|
| 5. Consolidation & Endgame Transition |
Endgame policy packages (smokefree generation law, nicotine reduction regs, sinking lid supply quotas), cross-border enforcement agreements |
Intensive cessation targeting, final supply reduction, global coordination |
National enforcement hubs, customs checkpoints, international treaty meetings |
Federal agencies (FDA, CBP), WHO FCTC Secretariat, neighboring country regulators |
Final push period before prevalence <5%, synchronized international enforcement |
Eliminate commercial tobacco use, prevent cross-border leakage |
|
| 6. Sustainment / Sunset |
Post-endgame monitoring systems, cultural norm education materials, illicit trade intelligence systems |
Long-term surveillance, preventive education, resource reallocation to other public health areas |
Local community health networks, schools, customs & border patrol |
Sustained public health teams, community educators, law enforcement |
Continuous post-endgame monitoring cycles |
Prevent relapse, maintain tobacco-free norms, safeguard public health gains |
|
